December 27, 2012
Apple (NASDAQ: AAPL ) and Google (NASDAQ: GOOG ) are among the most prominent and obvious beneficiaries of the explosion of mobile technology in the health-care industry. Participants at the recent 2012 mHealth Summit learned how these companies' phones, tablets, and operating systems allow providers to lower costs and offer better service.
Networking technology from the likes of Verizon (NYSE: VZ ) are also key in this area. One example is the life-altering technology invented by Dr. Richard Garfein of the University of California, San Diego. Tuberculosis is one of the world's deadliest infectious diseases, affecting more than 11 million people worldwide. Thanks to a grant from Verizon, Dr. Garfein explains in this video how he's able to offer this simple and cost-saving application on a global basis.
There's no doubt that Apple is at the center of technology's largest revolution ever, and that longtime shareholders have been handsomely rewarded with over 1,000% gains. However, there is a debate raging as to whether Apple remains a buy. The Motley Fool's senior technology analyst and managing bureau chief, Eric Bleeker, is prepared to fill you in on both reasons to buy and reasons to sell Apple, and what opportunities are left for the company (and more importantly, your portfolio) going forward. To get instant access to his latest thinking on Apple, simply click here now.